HVAC Section Head
About the job
- A bachelor's degree in Mechanical Engineering, Mechatronics, or a related field is required.
- Eight to twelve years of experience in HVAC systems is required; experience in pharmaceutical or biotech manufacturing is preferred.
- Strong knowledge of cleanroom HVAC design, chilled water plants, HEPA filtration, and Good Manufacturing Practice is required.
- Hands-on experience with Building Management Systems, variable-frequency drives, chiller controls, and HVAC automation is required.
- Proven leadership and project management capabilities are required.
- Lead daily operation of all HVAC systems, including air handling units, fresh air units, supply and exhaust fans, and local ventilation systems; ensure stable temperature, humidity, airflow, and pressure differentials in production and storage areas; monitor HVAC performance through Building Management Systems and Supervisory Control and Data Acquisition and optimize system efficiency.
- Ensure HVAC operations meet Good Manufacturing Practice, Food and Drug Administration, European Medicines Agency, World Health Organization, and local regulatory requirements; manage HEPA filter integrity testing, validation, and requalification schedules; develop and maintain HVAC standard operating procedures, work instructions, and risk assessments.
- Plan and supervise preventive and corrective maintenance; ensure proper calibration of temperature, humidity, and differential pressure; improve equipment reliability through predictive maintenance, condition monitoring, and root cause failure analysis.
- Lead energy conservation initiatives for HVAC and chilled water systems; optimize chiller loading, pump curves, fan energy consumption, and heat recovery; recommend system upgrades, retrofits, or technological improvements.
- Lead and develop the HVAC engineering and technician team; coordinate training on Good Manufacturing Practice HVAC operation and maintenance; assign tasks, monitor performance, and ensure continuous skill development.
- Lead HVAC-related capital projects; review engineering designs, piping and instrumentation diagrams, layout drawings, and technical submittals; ensure project execution meets timelines, budget, and quality requirements.
- Maintain HVAC logs, maintenance records, and equipment history files; prepare reports on system performance, downtime, energy consumption, and compliance; support audits and provide required documentation.
- Experience in pharmaceutical or biotech manufacturing is preferred.
About the company
EVA Pharma develops and manufactures affordable medicines for global markets, focusing on 12 therapeutic areas such as anti-infectives, metabolic health, oncology, and pediatrics. It operates four manufacturing facilities with a 5,000-strong team and produces over one million healthcare products daily. The company runs two regional research centers that use AI-driven prediction and mRNA R&D to develop biological products and first-of-its-kind capabilities in the Middle East and Africa. EVA Pharma distributes its products to more than 60 countries and seeks to expand access to high-quality medicines worldwide. Its differentiation comes from its scale, regional R&D capabilities, and commitment to sustainable access, aiming to meet pressing, unmet disease needs with reliable supply.
Company Size
1,001-5,000
Company Stage
N/A
Total Funding
N/A
Headquarters
Al Sharikat, Egypt
Founded
1997
Get referred to Eva Pharma
See people who can refer or advise you
Simplify's Take
What believers are saying
- Egypt’s December 2024 insulin approval opens exportable manufacturing revenues and credibility with regulators.
- November 2025 EVA Pharma Oncology targets 22 million packs annually, with 11 more treatments planned.
- Access-heavy partnerships with Gilead, BeiGene, and Porton create multiple near-term revenue streams.
What critics are saying
- Gilead’s generic lenacapavir supply starts 2027, so execution delays destroy EVA Pharma’s moat.
- Oncology launches need Egypt market uptake; BRUKINSA, TEVIMBRA, and seven in-house products face entrenched competitors.
- Any FDA, EDA, or Gilead tech-transfer setback blocks EVA Pharma’s pivot into high-value biologics.
What makes Eva Pharma unique
- Egypt’s 2024 Lilly insulin approval proves EVA Pharma can localize complex biologics manufacturing.
- The 2024 Gilead lenacapavir license makes EVA Pharma Africa’s sole local generic producer.
- The 2025 BeiGene deal and 2025 Porton MOU extend EVA Pharma beyond generics into oncology and CAR-T.
Help us improve and share your feedback! Did you find this helpful?
Benefits
- Hybrid Work Options